HKU Scholars Hub: Browsing DSpace

Browsing by Author Bendell, JC

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 7 of 7

	Title	Author(s)	Issue Date
	A phase II study of capecitabine, oxaliplatin, and bevacizumab in the treatment of metastatic esophagogastric adenocarcinomas Journal:Oncologist	Uronis, HE Bendell, JC Altomare, I Blobe, GC David Hsu, S Morse, MA Pang, H Yousuf Zafar, S Conkling, P Favaro, J Arrowood, CC Cushman, SM Meadows, KL Brady, JC Nixon, AB Hurwitz, HI	2013
	A phase II study of capecitabine, oxaliplatin, bevacizumab and cetuximab in the treatment of metastatic colorectal cancer Journal:Anticancer Research	Wong, NS Fernando, NH Nixon, AB Cushman, S Aklilu, M Bendell, JC Morse, MA Blobe, GC Ashton, J Pang, H Hurwitz, HI	2011
	A phase II study of oxaliplatin, dose-intense capecitabine, and high-dose bevacizumab in the treatment of metastatic colorectal cancer Journal:Clinical Colorectal Cancer	Wong, NS Fernando, NH Bendell, JC Morse, MA Blobe, GC Honeycutt, W Pang, H Hurwitz, HI	2011
	A phase II trial of bevacizumab plus everolimus for patients with refractory metastatic colorectal cancer Journal:Oncologist	Altomare, I Bendell, JC Bullock, KE Uronis, HE Morse, MA Hsu, SD Zafar, SY Blobe, GC Pang, H Honeycutt, W Sutton, L Hurwitz, HI	2011
	A phase I study of ABT-510 plus bevacizumab in advanced solid tumors Journal:Cancer Medicine	Uronis, HE Cushman, SM Bendell, JC Blobe, GC Morse, MA Nixon, AB Dellinger, A Starr, MD Li, H Meadows, K Gockerman, J Pang, HMH Hurwitz, HI	2013
	Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors Journal:Invest New Drugs	Rangwala, F Bendell, JC Kozloff, MF Arrowood, CC Dellinger, A Meadows, J Tourt-Uhlig, S Murphy, J Meadows, KL Starr, A Broderick, S Brady, JC Cushman, SM Morse, MA Uronis, HE Hsu, SD Zafar, SY Wallace, J Starodub, AN Strickler, JH Pang, HMH Nixon, AB Hurwitz, HI	2014
	Use of plasma angiome to predict PFS in patients with metastatic colorectal cancer (mCRC) treated with capecitabine, oxaliplatin, and bevacizumab (XELOX-A) Proceeding/Conference:Journal of Clinical Oncology	Nixon, A Starr, M Pang, HMH Bulusu, A Honeycutt, W Amara, A Bendell, JC Hurwitz, H	2010

Showing results 1 to 7 of 7